BRUIN CLL-321 study is now published

I'm sharing the BRUIN CLL-321 study now out in JCO: The first randomized Ph3 study conducted exclusively in covalent BTKi-pretreated #CLL/SLL, evaluating a non-covalent BTKi vs idelalisib/rituximab or bendamustine/rituximab.

Full results and supplemental resources: e.lilly/4kA96k4

#LeuSky #OncSky

@jkanermd.bsky.social is here! now the #leusky conversation can truly begin.

Today is my 5th Rebirthday! And it is the best. Making that 100% 5yr OS, DFS stat for the biphenotypic (B/Tcell) leukemias (n=1) is absolutely amazing! Cheers to living disease free. 🥳 Back to research I go. #leusky #BMTsky #oncosky #celltherapies

I guess it’ll be #bmtsky and #leusky which makes them seem distinctly Slavic. Not much for either yet, but we can change that! I’m rather enjoying the extra 25-or-so characters here too.